News

Some dreams can be magical. Others confusing. But most have some element of mystery. Dr. Thomas Uhde has always been fascinated by the science behind them.

Two nurses on the inpatient unit of MUSC Hollings Cancer Center have been honored for their work with the Palmetto Gold.

Is the decline of the BA.4 and BA.5-driven COVID wave in sight - or even already underway?

A national study is assessing whether online courses on pain management can help cancer patients.

A clinical trial at MUSC Hollings Cancer Center will investigate if a common statin could lead to a stronger anti-tumor response in prostate cancer patients.

New COVID data from the Medical University of South Carolina show the Omicron subvariants BA.4 and BA.5 have taken over.

“Now we’re part of the family,” one MUSC Health Midlands employee says as division celebrates first anniversary.

New hospital partnership connects mothers of preterm babies with breast pumps, quality nutritional resources.

She's been known as an innovator in instructional technology, an educator, a leader and mentor to faculty, staff and students.

MUSC Health is reaching out to patients at higher risk of getting monkeypox to let them know about vaccine offered by DHEC.